Innate Immune Cell Phenotypes and Early Fibrotic Repair in Acute Myocardial Infarction

Sponsor
Shanghai 10th People's Hospital
Study ID
NCT07764588
Status
Recruiting
Apply to this trial

Conditions

  • Myocardial Infarction

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Study Details

To determine the relationship of the phenotypes of neutrophils and monocytes with early fibrotic repair after acute myocardial infarction.

Key Dates

First listed
Aug 14, 2026
Start date
Jan 1, 2026
Status verified
Aug 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
50 participants (estimated)

Arms

  • Arm: STEMI patients
    Patients with acute STEMI within 12 hours of symptom onset receive primary percutaneous coronary intervention.

Primary Outcome Measure

Major cardiac adverse outcome [ Time Frame: At 12 months after enrollment ]

Central Contacts

Related Studies